Status:
COMPLETED
HD11 for Intermediate Stages
Lead Sponsor:
University of Cologne
Conditions:
Hodgkin´s Lymphoma
Eligibility:
All Genders
16-75 years
Phase:
PHASE3
Brief Summary
This study is designed to (1) compare the efficacy of the BEACOPP regimen with that of ABVD as a 4-cycle chemotherapy combined with an involved field irradiation and (2) to define the optimum radiatio...
Eligibility Criteria
Inclusion
- Hodgkin´s lymphoma (histologically proven)
- CS (PS) IA, IB, IIA, with one of the risk factors a-d CS (PS) IIB only with risk factor c or d
- bulky mediastinal mass (\> 1/3 maximum transverse thorax diameter)
- extranodal involvement
- ESR \> 50 (A), \> 30 (B-symptoms)
- 3 or more lymph node areas involved
- written informaed consent
Exclusion
- Leukocytes \<3000/microl
- Platelets \<100000/microl
- Hodgkin´s Disease as "composite lymphoma"
- Activity index (WHO) \< grade 2
Key Trial Info
Start Date :
May 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1395 Patients enrolled
Trial Details
Trial ID
NCT00264953
Start Date
May 1 1998
Last Update
August 4 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.